Article Details

Pfizer Provides Update on US FDA Review of Abrocitinib and XELJANZ® Filings | pfpfizeruscom

Retrieved on: 2021-07-22 09:10:44

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Provides Update on US FDA Review of Abrocitinib and XELJANZ® Filings | pfpfizeruscom. View article details on hiswai:

Excerpt

The FDA cited its ongoing review of Pfizer's post-marketing safety study, ORAL Surveillance, evaluating tofacitinib in rheumatoid arthritis patients, as a ...

Article found on: www.pfizer.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up